CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
NCT00925756
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Maraviroc
Sponsor
University of California, San Diego
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]